Clicks Group is to dispose of its shareholding in its pharmaceutical manufacturing subsidiary Unicorn Pharmaceuticals, and is confident the sale will be completed by the end of July.

The move follows the judgment by the Constitutional Court in March 2023 in the case of the Independent Community Pharmacy Association vs Clicks Group and the referral to the director-general of the department of health to determine sanction...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.